» Articles » PMID: 36518039

Quercetin and Its Role in Reducing the Expression of Pro-inflammatory Cytokines in Osteoarthritis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis is the most common human joint disease in the world. It is also one of the most common skeletal muscle defects, destructive joint changes, and the leading cause of disability and reduced quality of life. Destructive changes in inflammatory joints are associated with a range of biochemical events, including the overproduction of inflammatory cytokines. Cytokines are protein compounds that play an essential role in causing and regulating inflammation. A balance between pro-inflammatory and anti-inflammatory cytokines is crucial in maintaining a stable body. In some inflammatory diseases, including osteoarthritis, the balance between these compounds is disturbed, and the balance shifts to pre-inflammatory cytokines. For this reason, researchers today are trying to find an effective way to reduce inflammation and treat osteoarthritis by using certain compounds. Current treatments for osteoarthritis, including nonsteroidal antiinflammatory drugs, glucocorticoids, and hyaluronic acid, are mainly based on reducing pain and inflammation. However, they have limited effects in controlling symptoms and improving the patient's quality of life. Also, due to the high level of side effects, synthetic drugs have led to the identification of compounds of natural origin to give patients a chance to use painkillers and antiinflammatory drugs with fewer side effects. This review study aimed to present the role of quercetin as a natural compound in reducing the expression of pro-inflammatory cytokines in osteoarthritis. This study also discusses the relationship between inflammation and cartilage destruction and other inflammation-related factors caused by cytokines.

Citing Articles

Quercetin attenuates the symptoms of osteoarthritis and by suppressing ferroptosis via activation of AMPK/Nrf2/Gpx4 signaling.

Dong S, Li X, Xu G, Chen L, Zhao J Mol Med Rep. 2024; 31(3.

PMID: 39717946 PMC: 11711930. DOI: 10.3892/mmr.2024.13425.


Network pharmacology unveils the active components and potential mechanism of traditional efficacy of Mugua.

Wu Y, Yue S Medicine (Baltimore). 2024; 103(51):e41028.

PMID: 39705460 PMC: 11666192. DOI: 10.1097/MD.0000000000041028.


Structure-Function Relationships and Health-Promoting Properties of the Main Nutraceuticals of the Cactus Pear ( spp.) Cladodes: A Review.

Koufan M, Choukrane B, Mazri M Molecules. 2024; 29(19).

PMID: 39407660 PMC: 11477999. DOI: 10.3390/molecules29194732.


Validation of Jianpi Qingre Tongluo Recipe in Reducing Inflammation and Dyslipidemia in Osteoarthritis via Lnc RNA HOTAIR/APN/PI3K/AKT.

Chen X, Liu J, Wang G, Sun Y, Ding X, Zhang X Int J Gen Med. 2024; 17:3293-3318.

PMID: 39081673 PMC: 11288358. DOI: 10.2147/IJGM.S466148.


Different binding modalities of quercetin to inositol-requiring enzyme 1 of S. cerevisiae and human lead to opposite regulation.

Mahdizadeh S, Granden J, Pelizzari-Raymundo D, Guillory X, Carlesso A, Chevet E Commun Chem. 2024; 7(1):6.

PMID: 38177336 PMC: 10767055. DOI: 10.1038/s42004-023-01092-0.